Quote For Amylin Pharmaceuticals, Inc. AMLN.O

Amylin Pharmaceuticals, Inc. (AMLN.O) (Nasdaq)
sector: Healthcare · industry: Biotechnology ·
As of  25 Nov 2009
13.91USD
Price Change
+0.67
Percent Change
+5.06%
 
Research a stock:   symbol lookup
$13.91
25 Nov 2009
+5.06%
$13.91
--
3,427,078
$14.06
$13.25
$15.69
$5.92
1.66
1,686,285

News

Press Releases

Key Developments

Officers

Name Current Position Compensation
Costa, Paulo Chairman of the Board --
Bradbury, Daniel President, Chief Executive Officer, Director 4,059,276
Foletta, Mark Chief Financial Officer, Senior Vice President - Finance 1,252,962

Key Ratios and Statistics

Share Related Items
Market Cap (Mil.) $1,971.64
Shares Outstanding (Mil.) 141.74
Float (Mil.) 138.00
Dividend Information
Yield % -99,999.99
Annual Dividend ($ USD) 0.00
Payout Ratio(TTM) % --
Financial Strength
Quick Ratio 2.93
Current Ratio 3.15
LT Debt/Equity 159.19
Total Debt/Equity 165.94
Valuation Ratios
Price/Earnings(TTM) --
Price/Sales(TTM) 2.41
Price/Book(TTM) 4.26
Price/Cash Flow(TTM) --
Per Share Data
Earnings(TTM) $-1.73
Sales(TTM) $5.85
Book Value(MRQ) $3.26
Cash Flow(TTM) $-1.49
Cash(MRQ) $4.37
Management Effectiveness
Return on Equity(TTM) -52.93
Return on Assets(TTM) -14.57
Return on Investment(TTM) -17.53
Margins
Gross Margin(TTM) % 89.34
Operating Margin(TTM) % -27.71
Profit Margin(TTM) % -29.39

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement